Briefcase

The Burden of Anemia in CKD

Launch Date
12/12/2023
Credit Amount
0.5
Credit Expires
12/12/2024
This activity is part of a series

Faculty

Ellie Kelepouris, MD, FACP, FAHA
Professor of Medicine (Nephrology)
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Ellie Kelepouris, MD, FACP, FAHA

Ellie Kelepouris, MD, FACP, FAHA, is an attending nephrologist and professor of clinical medicine at the Perelman School of Medicine of the University of Pennsylvania in Philadelphia as well as a fellow of the American College of Physicians. She was previously the Chief of Nephrology, the fellowship training program director, and the interim chair of the Department of Medicine at Drexel University College of Medicine in Philadelphia. Dr. Kelepouris is a principal investigator in numerous clinical studies in nephrology, and her prolific list of publications includes many original research papers, reviews, abstracts, and book chapters. She also serves as a reviewer for several journals, including The Journal of Clinical Investigation, Clinical Journal of the American Society of Nephrology, Kidney International, and the American Journal of Kidney Diseases.

Dr. Kelepouris is a nationally recognized leader in the nephrology field. She served as the chair of the medical advisory board of the National Kidney Foundation for 15 years as well as on the leadership committee of the American Heart Association’s National Council on the Kidney in Cardiovascular Disease. As a strong patient advocate, she spearheaded many community engagement and kidney health screening programs in Philadelphia. For these efforts, she was honored by the National Kidney Foundation as Physician of the Year in 2020. In addition, she is actively involved in many professional organizations, including the American College of Physicians, the American Heart Association, and the American Society of Nephrology.

Dr. Kelepouris is the recipient of many awards in medicine and teaching, which include the Christian R. and Mary F. Lindback Award for Distinguished Teaching, Outstanding Physician of the Year and Outstanding Leadership Award from the National Kidney Foundation, and the Teaching and Mentoring Award from Drexel University College of Medicine. In 2018, Dr. Kelepouris was elected to a 3-year term as president of Women In Nephrology, a mentoring and leadership society for young professionals in the nephrology field.

Explore By Section
Statement of Need Learning Objective Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Chronic kidney disease (CKD) is a progressive loss of kidney function that often results in end-stage kidney disease (ESKD) and requires treatment with dialysis. Anemia is a frequent CKD complication characterized by symptoms such as fatigue, weakness, and diminished concentration; more than half of CKD patients experience anemia by stage 4 CKD compared to only 8% at stage 1. Patients frequently report CKD-related anemia burdens of increased morbidity and mortality, excessive health care costs, work productivity impairment, and lower quality of life. This burden weighs disproportionally upon underserved patient populations that include racial and ethnic minorities. Clinicians in the CKD field have the important undertaking of appropriate anemia recognition and treatment for all patients and must thus understand this crucial aspect of CKD management.

In the first activity of this CME Outfitters BriefCase series, expert faculty utilize case-based learning to evaluate the burden of CKD-related anemia, with a focus on patient populations undergoing dialysis who are at risk for receiving poorer care and experiencing worse outcomes.

Learning Objective

Evaluate the burden of CKD-related anemia, particularly among underserved patient populations on dialysis who are at risk for receiving poorer care and experiencing worse outcomes

Financial Support

This educational activity is supported by an educational grant from GSK.

Target Audience

Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in nephrology or primary care

Credit Information

Jointly accredited provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.5

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.5

This activity is designated for 0.50 contact hours.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.50 contact hours ( 0.05 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-141-H01-P ).

PAs (AAPA) 0.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 11/30/2024. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.5

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Kelepouris reports the following financial relationships:

Advisory Board: AstraZeneca; Bayer: Boehringer Ingelheim Pharmaceuticals Inc. and Lilly Alliance; CSL Vifor; and GSK

Consultant: Travere Therapeutics, Inc.

Disclosures were obtained from the following peer reviewers and CME Outfitters, LLC, staff, with no disclosures to report:

  • Jeffrey Helfand, DO (peer reviewer)
  • Karla E. Crews, MSN, RN (peer reviewer)
  • Keshia Pitt, PhD (planning committee)
  • John Jones, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

BC-105-121223-06

The Burden of Anemia in CKD
Event Date: 12/12/2023
Register